Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

66°
- West Point, MS (39773)
  Today
  
  Considerable cloudiness. High 78F. Winds SSW at 10 to 15 mph..
  
  Tonight
  
  Partly cloudy this evening with more clouds for overnight. Slight chance of a shower late. Low 63F. Winds light and variable.
  
  Updated: November 18, 2025 @ 9:49 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Local Events
e-Edition
Classifieds
- Place an ad
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

8.860 +0.590 (+7.13%)

Streaming Delayed Price Updated: 11:10 AM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Biohaven Ltd. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Recap: Biohaven Pharma Hldgs Q2 Earnings ↗

August 05, 2022

Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion ↗

August 05, 2022

Shares of Pfizer's rumored takeover target have rocketed for two days running.

Via Investor's Business Daily

The 3 Best Market Sectors for the Second Half of 2022 ↗

July 27, 2022

Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.

Via InvestorPlace

Which Coronavirus Stock Could Fetch Higher Returns? ↗

July 11, 2022

This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns.

Via InvestorPlace

Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit? ↗

July 05, 2022

The FDA's advisors recently backed Pfizer's Covid shot for young children.

Via Investor's Business Daily

Biohaven's Neurological Disease Candidate Flunks In Late-Stage Study ↗

May 23, 2022

Via Benzinga

Recap: Biohaven Pharma Hldgs Q1 Earnings ↗

May 10, 2022

Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Via Benzinga

Hopeful Golden Cross Forms On Biohaven Pharma Hldgs's Chart ↗

June 23, 2022

If history is any guide, there may be good fortune ahead for shares of Biohaven Pharma Hldgs (NYSE:BHVN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish...

Via Benzinga

Looking Into Biohaven Pharmaceutical's Return On Capital Employed ↗

June 10, 2022

According to data from Benzinga Pro, during Q1, Biohaven Pharmaceutical's (NYSE:BHVN) reported sales totaled $318.85 million. Despite a 41.43% increase in earnings, the company posted a loss of $116.90...

Via Benzinga

3 Biotech Stocks to Buy Before They Boom ↗

June 01, 2022

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

Via InvestorPlace

Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way ↗

May 24, 2022

The company is planning to soon ask for FDA approval of etrasimod in ulcerative colitis.

Via Investor's Business Daily

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

Stock Market Tries To Bounce From Fresh 2022 Lows; Tesla CEO Elon Musk Puts Twitter Deal 'On Hold': Weekly Review ↗

May 13, 2022

Elon Musk put his Twitter deal "on hold" but says he's "still committed" to it.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022 ↗

May 11, 2022

Upgrades

Via Benzinga

Why Is Biohaven Pharmaceutical (BHVN) Stock Up Today? ↗

May 10, 2022

BHVN stock is enjoying a nearly 70% jump today after Biohaven Pharmaceutical announced it has been acquired by Pfizer.

Via InvestorPlace

103 Biggest Movers From Yesterday ↗

May 11, 2022

Gainers

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; Crude Oil Down 3% ↗

May 10, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 10, 2022

Via Benzinga

Dow Reverses Morning Rally as Recession Fears Swirl ↗

May 10, 2022

Stocks are shedding their premarket gains at midday, and are now looking to extend yesterday's major selloff.

Via Talk Markets

Mid-Day Market Update: U.S. Stocks Turn Lower; Biohaven Pharmaceutical Shares Jump ↗

May 10, 2022

U.S. stocks turned mostly lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday.

Via Benzinga

77 Stocks Moving In Tuesday's Mid-Day Session ↗

May 10, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Pfizer Buys Biohaven In A $12 Billion Deal That 'Couldn't Have Come At A Better Time' ↗

May 10, 2022

One analyst says the deal "couldn't have come at a better time." Here's why.

Via Investor's Business Daily

Pfizer Acquires This Migraine Drug Maker For $11B: What Investors Need To Know ↗

May 10, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 10, 2022

Via Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

European Commission Granted Marketing Authorization For Pfizer and Biohaven's VYDURA® (Rimegepant) For Migraine ↗

April 27, 2022

European Commission (EC) has granted marketing authorization for VYDURA® (rimegepant) for both the acute treatment of migraine with or without aura, and prophylaxis of episodic migraine in adults who...

Via Benzinga

Axsome Therapeutics' Good Fortune Reverses As Its Migraine Drug Hits A Hurdle ↗

April 25, 2022

Last week, Axsome stock soared on its depression drug. This week is a different story.

Via Investor's Business Daily

AbbVie Stock Breaks Its Stride As Key Executive Departs For Flagship ↗

April 13, 2022

Flagship Pioneering is swiping one of AbbVie's biggest names.

Via Investor's Business Daily

Biohaven Pharma Holdings Stock Joins Elite Club Of Stocks With RS Ratings Over 90 ↗

April 06, 2022

On Wednesday, Biohaven Pharma Holdings stock had its Relative Strength (RS) Rating upgraded to 92 from 86 a day ago.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Announcements
Obituaries
Local Events
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Daily Times Leader

DailyTimesLeader.com
West Point, MS 39773
Phone: 662-323-1642
Email: editor@dailytimesleader.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

West Point, MS (39773)

Today

Tonight

Biohaven Ltd. Common Shares (NY:BHVN)

Headline News about Biohaven Ltd. Common Shares

Sections

Services

Daily Times Leader